Cargando…
Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis
This study aimed to identify baseline metabolic biomarkers for response to methotrexate (MTX) therapy in rheumatoid arthritis (RA) using an untargeted method. In total, 82 baseline plasma samples (41 insufficient responders and 41 sufficient responders to MTX) were selected from the Treatment in the...
Autores principales: | Gosselt, Helen R., Muller, Ittai B., Jansen, Gerrit, van Weeghel, Michel, Vaz, Frédéric M., Hazes, Johanna M. W., Heil, Sandra G., de Jonge, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768454/ https://www.ncbi.nlm.nih.gov/pubmed/33321888 http://dx.doi.org/10.3390/jpm10040271 |
Ejemplares similares
-
Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients
por: Gosselt, Helen R., et al.
Publicado: (2021) -
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio
por: Gosselt, Helen R., et al.
Publicado: (2020) -
Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis
por: Gosselt, Helen R., et al.
Publicado: (2021) -
Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis
por: Muller, Ittai B, et al.
Publicado: (2020) -
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
por: Fuentelsaz-Romero, Sara, et al.
Publicado: (2021)